DE69926052T2 - Menschliche Suppressor-tRNA Oligonukleotide Verfahren für deren Verwendung - Google Patents

Menschliche Suppressor-tRNA Oligonukleotide Verfahren für deren Verwendung Download PDF

Info

Publication number
DE69926052T2
DE69926052T2 DE69926052T DE69926052T DE69926052T2 DE 69926052 T2 DE69926052 T2 DE 69926052T2 DE 69926052 T DE69926052 T DE 69926052T DE 69926052 T DE69926052 T DE 69926052T DE 69926052 T2 DE69926052 T2 DE 69926052T2
Authority
DE
Germany
Prior art keywords
trna
sequence
vector
oligonucleotide
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69926052T
Other languages
German (de)
English (en)
Other versions
DE69926052D1 (de
Inventor
G. Rekha PANCHAL
J. Charles LINK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Gene Therapy Research Institute
Original Assignee
Human Gene Therapy Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Gene Therapy Research Institute filed Critical Human Gene Therapy Research Institute
Application granted granted Critical
Publication of DE69926052D1 publication Critical patent/DE69926052D1/de
Publication of DE69926052T2 publication Critical patent/DE69926052T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04B—TRANSMISSION
    • H04B10/00—Transmission systems employing electromagnetic waves other than radio-waves, e.g. infrared, visible or ultraviolet light, or employing corpuscular radiation, e.g. quantum communication
    • H04B10/25—Arrangements specific to fibre transmission
    • H04B10/2589—Bidirectional transmission
    • H04B10/25891—Transmission components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Electromagnetism (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DE69926052T 1998-01-14 1999-01-13 Menschliche Suppressor-tRNA Oligonukleotide Verfahren für deren Verwendung Expired - Lifetime DE69926052T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7141698P 1998-01-14 1998-01-14
US71416P 1998-01-14
PCT/US1999/000717 WO1999036519A1 (en) 1998-01-14 1999-01-13 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME

Publications (2)

Publication Number Publication Date
DE69926052D1 DE69926052D1 (de) 2005-08-11
DE69926052T2 true DE69926052T2 (de) 2006-04-27

Family

ID=22101183

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69926052T Expired - Lifetime DE69926052T2 (de) 1998-01-14 1999-01-13 Menschliche Suppressor-tRNA Oligonukleotide Verfahren für deren Verwendung

Country Status (8)

Country Link
US (2) US6309830B1 (cg-RX-API-DMAC7.html)
EP (1) EP1045902B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002508959A (cg-RX-API-DMAC7.html)
AT (1) ATE299179T1 (cg-RX-API-DMAC7.html)
AU (1) AU2225199A (cg-RX-API-DMAC7.html)
CA (1) CA2318374C (cg-RX-API-DMAC7.html)
DE (1) DE69926052T2 (cg-RX-API-DMAC7.html)
WO (1) WO1999036519A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508959A (ja) * 1998-01-14 2002-03-26 ヒューマン ジーン セラピー リサーチ インスティテュート ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法
KR20010079671A (ko) * 1998-08-20 2001-08-22 스티븐 에이. 서윈. 엠.디. 재조합 유전자 생성물을 생성시키는 동안 세포독성을조절하는 억제 tRNA의 용도
WO2003033521A1 (en) * 2001-10-16 2003-04-24 Massachusetts Institute Of Technology Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides.
US20050261210A1 (en) * 2004-02-19 2005-11-24 Bhatnagar Rajiv S Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders
WO2005086768A2 (en) * 2004-03-11 2005-09-22 Albert Einstein College Of Medicine Of Yeshiva University Enhanced production of functional proteins from defective genes
WO2008064304A2 (en) * 2006-11-22 2008-05-29 Trana Discovery, Inc. Compositions and methods for the identification of inhibitors of protein synthesis
ATE553764T1 (de) * 2007-09-14 2012-05-15 Trana Discovery Zusammensetzungen und verfahren zur identifizierung von inhibitoren einer retrovirusinfektion
CA2776044A1 (en) * 2008-09-29 2010-04-01 Trana Discovery, Inc. Screening methods for identifying specific staphylococcus aureus inhibitors
CN107177592B (zh) * 2016-03-10 2021-03-30 北京大学 抑制性tRNA通读提前终止密码子疾病中的截短蛋白
CN110612353A (zh) * 2017-03-03 2019-12-24 加利福尼亚大学董事会 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
MX2020004587A (es) * 2017-11-02 2021-04-12 Univ Iowa Res Found Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt.
WO2020069194A1 (en) * 2018-09-26 2020-04-02 Case Western Reserve University Methods and compositions for treating a premature stop codon-mediated disorder
JP2022528696A (ja) * 2019-04-11 2022-06-15 アークタラス テラピュウティクス、インク アンチコドンループを延長した合成転移rna
LU101182B1 (en) * 2019-04-11 2020-10-12 Univ Hamburg Synthetic transfer RNA with extended anticodon loop
JP7712270B2 (ja) 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
US11827880B2 (en) 2019-12-02 2023-11-28 Shape Therapeutics Inc. Therapeutic editing
BR112022020780A2 (pt) 2020-04-14 2022-11-29 Flagship Pioneering Innovations Vi Llc Composições de trem e usos das mesmas
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
WO2022125531A1 (en) * 2020-12-07 2022-06-16 President And Fellows Of Harvard College Methods for making and using genomically recoded cells
AU2023212951A1 (en) * 2022-01-25 2024-08-29 Hc Bioscience, Inc. Universal suppressor trnas and uses thereof
USD1118947S1 (en) * 2024-05-29 2026-03-17 Shock Doctor, Inc. Knee brace
USD1121161S1 (en) * 2024-05-29 2026-03-31 Shock Doctor, Inc. Knee brace

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687737A (en) 1982-11-12 1987-08-18 Massachusetts Institute Of Technology Mammalian suppressor genes
US4970155A (en) * 1983-03-07 1990-11-13 Abbott Laboratories HSV helper virus independent vector
US6111095A (en) * 1995-06-07 2000-08-29 Merck & Co., Inc. Capped synthetic RNA, analogs, and aptamers
JP2002508959A (ja) * 1998-01-14 2002-03-26 ヒューマン ジーン セラピー リサーチ インスティテュート ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法

Also Published As

Publication number Publication date
CA2318374A1 (en) 1999-07-22
US7029665B2 (en) 2006-04-18
EP1045902A1 (en) 2000-10-25
US20020156042A1 (en) 2002-10-24
CA2318374C (en) 2012-09-04
JP2002508959A (ja) 2002-03-26
DE69926052D1 (de) 2005-08-11
WO1999036519A1 (en) 1999-07-22
EP1045902B1 (en) 2005-07-06
AU2225199A (en) 1999-08-02
ATE299179T1 (de) 2005-07-15
US6309830B1 (en) 2001-10-30
HK1033955A1 (en) 2001-10-05

Similar Documents

Publication Publication Date Title
DE69937243T2 (de) Überexpression von gewünschten proteinen in eukaryotischen zellen mittels überexpression von cyclin d1
EP1776460B2 (de) Verfahren zur modulation der genexpression durch änderung des cpg gehalts
DE69033975T2 (de) Rekombinanttherapien für Infektionen und hyperproliferative Störungen
US6309830B1 (en) Human suppressor tRNA oligonucleotides and methods of use for same
DE69131908T3 (de) Viruspartikel mit veraendertem wirtspektrum
DE69129897T2 (de) Methode des gentransfers mittels retrotransposons
DE69636248T2 (de) Expressionssysteme
DE69126606T2 (de) Vakzine
DE69128037T2 (de) Bifunktionelle wählbare fusionsgene
US6475798B2 (en) P element derived vector and methods for its use
DE69030740T2 (de) Rekombinantes DNS-Verfahren und Wirtszellen
WO2010130844A1 (de) Aslv-vektorsystem
DE60038555T2 (de) Verpackungszelle
AU2016373365A1 (en) Transposon system, kit comprising the same, and uses thereof
WO2000017233A2 (de) Gene des 1-desoxy-d-xylulose-biosynthesewegs
CA3068072A1 (en) Methods and compositions for assessing crispr/cas-mediated disruption or excision and crispr/cas-induced recombination with an exogenous donor nucleic acid in vivo
Panchal et al. Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA
DE102004037611B4 (de) Induzierbare Genexpression
WO1996033272A1 (de) Vektoren zur transfektion von eukaryotischen zellen, deren verwendung und damit transfizierte zielzellen
DE19822115B4 (de) Retrovirale Gentransfervektoren
DE60033517T2 (de) Invivo selektionsverfahren zur bestimmung von inhibierenden rna molekülen
DE69937556T2 (de) Amphotrope retrovirus-verpackungszelllinie, verfahren zur herstellung und verwendung
EP1428886A1 (de) Verbesserte retrovirale Vektoren für die Gentherapie
DE19807265C2 (de) Adenoviraler Transfervektor für den Gentransport einer DNA-Sequenz
WO2003092723A1 (de) Verwendung von fasl zur behandlung von neurodegenerativen erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition